Primer: Shanghai Medicilon (688202 CH) - Aug 2026
Shanghai Medicilon is a comprehensive preclinical Contract Research Organization (CRO) facing significant industry headwinds, including intense...
91 Views
𝛼SK or SearchENTITY
Shanghai Medicilon (688202 CH)
Shanghai Medicilon (688202 CH)
56
Analysis
Health Care • China
Shanghai Medicilon Inc. develops pharmaceutical products. The Company produces acquired immune deficiency syndrome drugs, anticancer drug sensitizers, genetic engineering vaccines, biomedical intermediates, and other products. Shanghai Medicilon also provides biological analysis, drug safety evaluation, and other services.
morex